These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2959458)

  • 1. [Contact allergy to the antifungal agent naftifin].
    Hoting E; Küchmeister B; Hausen BM
    Derm Beruf Umwelt; 1987; 35(4):124-7. PubMed ID: 2959458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic contact dermatitis to naftifine. Report of two cases.
    Senff H; Tholen S; Stieler W; Reinel D; Hausen BM
    Dermatologica; 1989; 178(2):107-8. PubMed ID: 2522401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic contact dermatitis from naftifine in a child without cross-reaction to terbinafine.
    Goday JJ; González-Güemes M; Yanguas I; Ilardia R; Soloeta R
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):72-3. PubMed ID: 9731972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic contact dermatitis to naftifine.
    Corazza M; Lauriola MM; Virgili A
    Contact Dermatitis; 2005 Nov; 53(5):302-3. PubMed ID: 16283912
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of naftifine (Exoderil) cream in the treatment of dermatophytosis.
    Lee CT; Giam YC; Tan T
    Singapore Med J; 1987 Oct; 28(5):429-31. PubMed ID: 3324355
    [No Abstract]   [Full Text] [Related]  

  • 6. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
    Ganzinger U; Stutz A; Petranyi G; Stephen A
    Acta Derm Venereol Suppl (Stockh); 1986; 121():155-60. PubMed ID: 3459341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration].
    Meinicke K; Striegel C; Weidinger G
    Mykosen; 1984 Dec; 27(12):608-14. PubMed ID: 6395017
    [No Abstract]   [Full Text] [Related]  

  • 8. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F; Gartmann H; Weidinger G
    Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naftifine: a topical allylamine antifungal agent.
    Mühlbacher JM
    Clin Dermatol; 1991; 9(4):479-85. PubMed ID: 1822408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H; Luszpinski P
    Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M; Péc J; Moravcík P
    Cas Lek Cesk; 1993 Jun; 132(13):406-9. PubMed ID: 8370053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naftifine treatment for dermatophytosis: multicenter clinical investigations in Turkey. Turkish Multicenter Dermatophytosis Study Group.
    Int J Dermatol; 1992 Apr; 31(4):247-8. PubMed ID: 1503576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Naftifin in severe dermatomycosis--controlled comparison of efficacy with econazole].
    Nolting S; Weidinger G
    Mykosen; 1985 Feb; 28(2):69-76. PubMed ID: 3885027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
    G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naftifine cream in the treatment of cutaneous candidiasis.
    Zaias N; Astorga E; Cordero CN; Day RM; de Espinoza ZD; DeGryse R; Rojas RF; Sefton J
    Cutis; 1988 Sep; 42(3):238-40. PubMed ID: 3048914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Group-allergic reaction spectrum and sensitization potency of benzylisothiocyanate].
    Richter G; Heidelbach U; Heidenbluth I; Kadner H
    Berufsdermatosen; 1976; 24(6):147-51. PubMed ID: 138417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D; Reichenberger M
    Mykosen; 1980 Dec; 23(12):657-68. PubMed ID: 7012610
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifungal activity of SN 105-843 gel in vivo.
    Haroon TS; Qazi AA; Khan KA; Farooqi AH
    J Pak Med Assoc; 1981 Jun; 31(6):123-6. PubMed ID: 6792389
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind clinical trial of fenticonazole (2%) spray versus naftifine (1%) spray in patients with cutaneous mycoses.
    Leiste D; Braun W; Fegeler W; Fegeler K; Stary A; Ruping KW; Klaschka F; Colli E; Sartani A
    Curr Med Res Opin; 1989; 11(9):567-75. PubMed ID: 2692971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia.
    Hira SK; Abraham MS; Mwinga A; Kamanga J; Schmidt C
    Mykosen; 1986 Aug; 29(8):378-81. PubMed ID: 3531847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.